Walgreens Boots Alliance (NASDAQ:WBA) Updates FY 2024 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 2.800-2.950 for the period, compared to the consensus estimate of 3.200. The company issued revenue guidance of -. Walgreens Boots Alliance also updated its FY24 guidance to $2.80-$2.95 EPS.

Analysts Set New Price Targets

Several research firms have weighed in on WBA. Bank of America reiterated an underperform rating and issued a $11.00 price target (down from $22.00) on shares of Walgreens Boots Alliance in a research report on Friday. Evercore ISI cut their price target on Walgreens Boots Alliance from $17.00 to $10.00 and set an in-line rating for the company in a report on Friday. Deutsche Bank Aktiengesellschaft decreased their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a hold rating on the stock in a research note on Wednesday, April 3rd. TD Cowen reduced their target price on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a buy rating for the company in a report on Wednesday, April 3rd. Finally, UBS Group lowered their price target on shares of Walgreens Boots Alliance from $22.00 to $17.00 and set a neutral rating on the stock in a report on Monday, June 24th. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of Hold and an average target price of $20.64.

Walgreens Boots Alliance Trading Down 0.8 %

WBA stock opened at $12.10 on Friday. Walgreens Boots Alliance has a twelve month low of $11.68 and a twelve month high of $31.32. The business’s fifty day simple moving average is $16.49 and its two-hundred day simple moving average is $20.17. The company has a current ratio of 0.65, a quick ratio of 0.32 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing analysts’ consensus estimates of $0.67 by ($0.04). The company had revenue of $36.40 billion during the quarter, compared to the consensus estimate of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The company’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.00 earnings per share. As a group, analysts predict that Walgreens Boots Alliance will post 2.94 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st were issued a $0.25 dividend. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.27%. Walgreens Boots Alliance’s payout ratio is -14.84%.

Insider Buying and Selling

In other news, CFO Manmohan Mahajan bought 6,000 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The stock was acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now directly owns 166,969 shares in the company, valued at approximately $3,235,859.22. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, April 2nd. The stock was bought at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is owned by insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.